Related Experiment Video
Updated: Jun 4, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Pharmacotherapy in pediatric sleep disorders
Shelly K Weiss1, Andrea Garbutt
1Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada. shelly.weiss@sickkids.ca
Insights
Pediatric sleep disorders impact learning and behavior. Treatment, including behavioral interventions and pharmacotherapy, requires accurate diagnosis and understanding of limited research, especially for adolescents.
Area of Science:
- Pediatric Sleep Medicine
- Pharmacology
- Child Psychology
Background:
- Sleep disorders are common in children and adolescents, affecting daytime functioning like learning, memory, attention, and behavior.
- Untreated sleep problems can lead to significant negative impacts on a child's development and daily life.
Purpose of the Study:
- To outline the pharmacologic treatment of sleep disorders in typically developing children and adolescents.
- To emphasize the importance of accurate diagnosis and understanding the role of pharmacotherapy.
Main Methods:
- Review of current literature on pediatric sleep disorders and their treatment.
- Discussion of the principles guiding pharmacotherapy and behavioral interventions.
- Focus on pharmacologic approaches for various pediatric sleep conditions.
Main Results:
- Behavioral interventions are effective for young children with insomnia, with less evidence for school-age children and adolescents.
- Pharmacotherapy for pediatric insomnia is not well-defined, often relying on adult data and off-label use.
- Specific sleep disorders beyond insomnia may warrant pharmacotherapy combined with behavioral strategies.
Conclusions:
- Accurate diagnosis is crucial for effective treatment of pediatric sleep disorders.
- Non-pharmacologic strategies are generally the first line of treatment, especially for insomnia.
- Further research is needed on pharmacotherapy for sleep disorders in pediatric populations.
Abstract:
Sleep disorders are highly prevalent during childhood and adolescence. It is known that if left untreated, these problems can have significant impact on daytime function, including learning, memory, attention, and behavior. The approach to the treatment of these disorders (whether with or without pharmacotherapy) is dependent on a thorough evaluation of the sleep complaint and determination of an accurate diagnosis. Many pediatric sleep problems are due to insomnia. There is good evidence that young children with behaviorally based insomnia respond to appropriate behavioral interventions. There is less research evidence of the efficacy of these interventions in children who are either school age or adolescents; however, nonpharmacologic strategies are usually indicated initially in the approach to treatment. The indication for the use of pharmacotherapy in pediatric insomnia is not well understood; however, some general principles are described when medications may be considered. There are specific sleep disorders (other than insomnia) for which pharmacotherapy plus behavioral strategies are warranted. The research regarding pharmacotherapy in pediatric sleep disorders is limited; often, medications are used "off label" based on data extrapolated from adult studies. Clinicians who suggest over-the-counter treatments or prescribe medications for pediatric patients with sleep disorders should have an understanding of the classification of sleep disorders and the role of pharmacotherapy in the treatment of these disorders. In this chapter, the emphasis is on the pharmacologic treatment of sleep disorders in typically developing children and adolescents.
More Related Videos
07:54Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Management of Insomnia
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution